Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1176 | 1073 | 1176 | 1199 | 1504 | 2416 |
Fund Return | 17.61% | 7.34% | 17.61% | 6.24% | 8.51% | 9.22% |
Place in category | 3 | 4 | 3 | 3 | 3 | 2 |
% in Category | 40 | 60 | 40 | 40 | 67 | 100 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
FirstChoice WS Inv CFS WS Geared Sh | 4.8B | 27.68 | 7.78 | 15.21 | ||
CFS FC W Pen FirstChoice W Moderate | 4.73B | 12.04 | 3.90 | 5.91 | ||
CFS FC ESup FirstChoice Moderate Se | 4.73B | 11.13 | 3.86 | 5.40 | ||
FirstChoice WS Inv FirstChoice WS M | 4.73B | 11.91 | 3.66 | 5.65 | ||
CFS FC W PSup FirstChoice W Moderat | 4.73B | 10.59 | 3.43 | 5.27 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard International Small Compan | 2.84B | 19.47 | 6.34 | 10.41 | ||
AU60MIN00172 | 1.68B | 21.00 | 6.21 | 9.98 | ||
AU60BPF00291 | 818.77M | 15.48 | 2.53 | 9.79 | ||
Dimensional Global Small Company Tr | 584.49M | 20.10 | 8.36 | 10.79 | ||
Yarra Global Small Companies Fund | 382.59M | 26.89 | 10.36 | 11.44 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
SPDR S&P Biotech | US78464A8707 | 4.01 | 93.54 | +1.04% | |
iShares MSCI EAFE Small-Cap | US4642882736 | 1.53 | 63.20 | +1.36% | |
Blue Bird | US0953061068 | 0.96 | 36.17 | -4.06% | |
BAWAG | AT0000BAWAG2 | 0.95 | 86.750 | +2.06% | |
Enova International Inc | US29357K1034 | 0.93 | 113.70 | +1.46% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review